Furthermore, elastase has been recently considered as a potential target for the prevention of acute respiratory distress syndrome (ARDS) in COVID-19 patients and the possible use of neutrophil elastase inhibitors to prevent and to treat these disorders has been hypothesized. The gene discussed is ELANE; the disease is COVID-19.